Faculty

The Pharmacotherapy Preparatory Review and Recertification Course content is developed by clinical and educational experts in pharmacotherapy. To learn more about the course faculty see below.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 25-26, 2020

Browse by Last Name | B | C | D | E | F | G | H | I | M | S | W | Z |

Deborah S. Bondi, PharmD, BCPS, BCPPS

Pediatrics

Dr. Bondi completed her Pharm.D. degree at the University of Missouri – Kansas City in Kansas City, MO. She completed both her PGY1 Pharmacy Residency and PGY2 Pediatric Pharmacy Residency at the University of Illinois at Chicago. She is currently a Pediatric Clinical Coordinator and Clinical Pharmacy Specialist in the Neonatal Intensive Care Unit at the University of Chicago Medicine, Comer Children’s Hospital. She additionally holds appointments as adjunct faculty at multiple schools of pharmacy. She is a board-certified Pharmacotherapy Specialist, as well as a board-certified Pediatric Pharmacy Specialist. She has served on several committees for ACCP, the Pediatric Pharmacy Association, as well as the ACCP Pediatric PRN. She also has served as an author for the PedSAP series and for the ACCP Guideline on Clinical Pharmacist Competencies. Her professional and research interests include the prevention and treatments of various complications of prematurity, blood pressure management in premature neonates, and neonatal pulmonary hypertension.

Mary M. Bridgeman, Pharm.D., BCPS

Geriatrics

Dr. Mary Bridgeman received her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey. After graduation, she completed a specialized pharmacy residency in Nephrology and Hypertension at Robert Wood Johnson University Hospital, New Brunswick, New Jersey. Mary has been at the Ernest Mario School of Pharmacy at Rutgers University since 2007 and is currently a Clinical Professor in the Department of Pharmacy Practice and Administration. She maintains a practice site in Internal Medicine at Robert Wood Johnson University Hospital-New Brunswick. Mary is recognized as a Board Certified Pharmacotherapy Specialist, Board Certified Geriatric Pharmacist, and Fellow of the American Society of Consultant Pharmacists.

Mary is actively involved in state, regional and national societies that serve the pharmacy profession, including the New Jersey Society of Health-Systems Pharmacists, the New Jersey Pharmacists Association, the American Society of Health-Systems Pharmacists, and the Accreditation Council for Pharmacy Education, to name a few. At both the university and hospital organizational levels, she is involved in committees charged with governing student development and patient care, respectively. At the state level, she is a member and co-chairwoman of the New Jersey Interagency Council on Osteoporosis and member of the New Jersey Medicinal Marijuana Review Panel. She is a peer-reviewer for several journals and has served as an item writer for the American College of Clinical Pharmacy’s mock board certification exam and reviewer for the organization’s annual Board Certified Pharmacotherapy Specialist review course.

John M. Burke, Pharm.D., FCCP, BCPS

Nephrology

John M. Burke is currently a professor of pharmacy practice and associate dean for postgraduate education at St. Louis College of Pharmacy. He earned his B.S. degree in pharmacy from the University of Missouri–Kansas City and his Pharm.D. degree from the University of Texas. He completed his clinical pharmacy residency at Truman Medical Center in Kansas City, Missouri. Burke is a Board Certified Pharmacotherapy Specialist and has been a clinical practitioner and faculty member for over 25 years.

Jacintha S. Cauffield, Pharm.D., BCPS

General Psychiatry

Dr. Cauffield received her Doctor of Pharmacy at University of Maryland, followed by a 2 year fellowship in family medicine at University of Florida under the direction of Dr. John Gums. Her career experience includes the West Palm beach VAMC and and the PeaceHealth Southwest Medical Group Residency Program in Vancouver, WA.

Currently she is an Associate Professor of Pharmacy Practice at Palm Beach Atlantic University’s Lloyd L. Gregory School of Pharmacy. She coordinates and teaches in the Neurologic and Psychiatric Pharmacotherapy series. She additionally maintains an ambulatory care practice site at a local safety net clinic.

Paul P. Dobesh, Pharm.D., FCCP, BCPS

Anticoagulation

Bachelor of Science in Pharmacy from South Dakota State University. Two year add-on Pharm.D. degree also from South Dakota State University. Internal Medicine Specialty Residency with the University of Texas at Austin at Brackenridge Hospital. He is currently Professor of Pharmacy Practice with the University of Nebraska Medical Center in Omaha, Nebraska.

Currently maintains clinical practice with cardiology services at Nebraska Medical Center. Responsible for teaching pharmacy and medical students as well as pharmacy and medical residents. Lectures in the area of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area. Dr. Dobesh was awarded the “Distinguished Educator or the Year” award at the University of Nebraska Medical Center College of Pharmacy in 2015, an award he has received 4 times since 2007. In 2013 he was also awarded the University of Nebraska Medical Center campus wide Outstanding Educator Award.

Shareen Y. El-Ibiary, Pharm.D., FCCP, BCPS

Men's and Women's Health

Dr. Shareen El-Ibiary is a professor of pharmacy practice at Midwestern University College of Pharmacy, Glendale, Arizona, and was previously a faculty member at the University of California–San Francisco (UCSF) School of Pharmacy for 7 years. She graduated from the University of South Carolina in 2000 and completed her general pharmacy practice residency at UCSF in 2001. Her areas of interest and clinical research include contraception, mood and hormones, postpartum depression, and pharmacogenomics. Dr. El-Ibiary has spoken on various women’s health topics, written book chapters, published papers, and developed continuing education programs related to women’s health topics. She is also involved in various local, state, and national pharmacy organizations. She is a fellow of ACCP and the California Society of Health-System Pharmacists and is a past chair for the Women’s Health PRN. Her other interests include pharmacy curriculum and innovative teaching. Dr. El-Ibiary has served as a faculty member for the American College of Clinical Pharmacy Updates in Therapeutics: The Pharmacotherapy Preparatory Review Course since 2010.

Christopher T. Elder, Pharm.D., BCOP

Oncology Support Care

Dr. Christopher Elder is an Assistant Professor of Pharmacy Practice at Palm Beach Atlantic University a role he has served in since 2017. Prior to joining Palm Beach Atlantic University Dr. Elder served as a Hematology/Oncology Clinical Pharmacist at Cone Health.

Dr. Elder graduated from South University with his doctorate in pharmacy, and then completed a PGY1 residency and a PGY2 residency in Oncology Pharmacy. He earned his board certification in oncology pharmacy in 2015. Dr. Elder is active in many professional associations including the American College of Clinical Pharmacy, and the American Society of Clinical Oncology

Shannon W. Finks, Pharm.D., FCCP, BCPS

Acute Care in Cardiology

Dr. Shannon Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC is Professor of Clinical Pharmacy at the University of Tennessee College of Pharmacy in Memphis. Dr. Finks has practiced for two decades in the area of cardiology and has expertise in private institution and academic practice settings. She is a Fellow of the American College of Clinical Pharmacy, and has Board Certifications in Pharmacotherapy and Cardiology, as well as specialty certifications in hypertension, precision medicine, and applied pharmacogenetics. Her current practice includes clinical pharmacy services with a focus on cardiovascular pharmacotherapy in an urgent care clinic setting. Her passion is teaching and has been awarded University-related teaching awards in 2010, 2012, and 2018. Dr. Finks is well published in the medical literature and has been invited to present locally, regionally, nationally, and internationally on numerous cardiovascular-related topics.

Caitlin M. Gibson, PharmD, BCPS, BCCP

Chronic Care in Cardiology

Dr. Gibson is Associate Professor and Vice Chair in the Pharmacotherapy Department at the University of North Texas System College of Pharmacy in Fort Worth, TX. She maintains a practice in inpatient cardiology on a telemetry unit and a cardiovascular ICU at Medical City Arlington. Dr. Gibson received her PharmD from the University of Texas at Austin, completed her PGY1 residency at the North Texas VA/Texas Tech, and completed her PGY2 at Indiana University Health/Butler University. Dr. Gibson has published numerous papers, abstracts, and book chapters focused on cardiovascular pharmacotherapy. Her professional interests include anticoagulation, cardiovascular surgery, and health disparities in cardiovascular disease state management.

Leslie A. Hamilton, Pharm.D, FCCP, BCCCP

Fluids, Electrolytes, and Nutrition

Leslie A. Hamilton, PharmD, FCCP, FCCM, BCPS, BCCCP, is an Associate Professor of Clinical Pharmacy and Translational Science at the University of Tennessee Health Science Center College of Pharmacy. She practices in neurology and critical care at UT Medical Center. Prior to joining UT, Dr. Hamilton served on faculty at Auburn University for three years and practiced in pulmonology and critical care. Her interests are critical care, neurology, nutrition, and infectious disease. She serves on several committees for AACP, ACCP, NCS, and SCCM.

Brian K. Irons, Pharm.D.,FCCP, BCACP

Endocrine and Metabolic Disorders

Brian K. Irons is a professor with the Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy and had served as the Division Head of Ambulatory Care from 2005-2019. He received his B.S. in pharmacy and Pharm.D. degrees from the University of Wisconsin and his B.S. degree in biology from the University of Wisconsin–Stevens Point. He completed a pharmacy practice residency at United Hospital in St. Paul, Minnesota, and a specialty residency in managed care/ambulatory care at the TTUHSC School of Pharmacy. He was a board-certified pharmacotherapy specialist in 2000-2014, is a board-certified ambulatory care pharmacist (2011-present), and held certification in advanced diabetes management from 2010 to 2017. Dr. Irons's practice on the Lubbock campus optimizes patient care for various disease states, including diabetes, hypertension, dyslipidemia, and anticoagulation, through pharmacist-physician collaborative drug therapy management in the TTUHSC Department of Internal Medicine. He was named as a Fellow of ACCP in 2011. He is a past chair of ACCP’s Ambulatory Care PRN and formally served as its secretary. He is a past chair and secretary/treasurer of the Endocrine and Metabolism PRN. Dr. Irons has served as a faculty member for the American College of Clinical Pharmacy Updates in Therapeutics®: The Pharmacotherapy Preparatory Review Course since 2010.

Ashley H. Meredith, Pharm.D.

Pulmonary Disorders, Gout, and Immunizations

Ashley Meredith is a clinical associate professor of pharmacy practice at the Purdue University College of Pharmacy in West Lafayette, Indiana. Her area of clinical practice is in adult primary care for Eskenazi Health in Indianapolis, Indiana.

Dr. Meredith earned her Pharm.D. degree at the University of Pittsburgh, School of Pharmacy in 2007, and she is board certified in both ambulatory care and pharmacotherapy, along with maintaining the Certified Diabetes Educator credentials.

Her professional interests include evaluating increased access to contraception through pharmacist prescribing, cardiovascular risk reduction disease state management, assessment of patient and provider satisfaction with pharmacist-managed clinics, and perceptions of community pharmacist prescribing privileges.

Curtis L. Smith, Pharm.D., BCPS

Infectious Diseases I; Infectious Diseases II; Pharmacokinetics

Dr. Curtis Smith received a bachelor’s degree from Ferris State University in Michigan and then completed a Pharm.D. degree at the Medical University of South Carolina. After completing a fellowship in pharmacokinetics and pharmacodynamics at the University of Oklahoma, he returned to Ferris State University as a faculty member at the School of Pharmacy. Dr. Smith is a professor, Ferris State University, and practices in pharmacokinetics in special populations, internal medicine, infectious diseases, and surgery/trauma. Dr. Smith is a board-certified pharmacotherapy specialist who has given presentations and published in pharmacokinetics and infectious diseases. Dr. Smith has served as a faculty member for the American College of Clinical Pharmacy Updates in Therapeutics: The Pharmacotherapy Preparatory Review Course since 2002.

Kevin M. Sowinski, Pharm.D., FCCP

Biostatistics; Study Designs

Dr. Kevin Sowinski is professor of pharmacy practice at the Purdue University College of Pharmacy and adjunct professor of medicine at the Indiana University School of Medicine.

Dr. Sowinski received a bachelor’s of science degree in pharmacy in 1990 and a Pharm.D. degree in 1992 at the University at Buffalo, State University of New York, School of Pharmacy and Pharmaceutical Sciences. From 1992 to 1995, he completed a postdoctoral fellowship in pharmacokinetics and pharmacodynamics at the University of Tennessee Health Science Center in Memphis. He has been at Purdue University since 1995.

Dr. Sowinski has served as chair of several ACCP committees and task forces as well as the ACCP Pharmacokinetics/Pharmacodynamics PRN. He has also served as a specialist member and chair of the Pharmacotherapy Specialty Council of the Board of Pharmacy Specialties.

Dr. Sowinski has published more than 100 original publications or abstracts, as well as more than 20 book chapters, letters, or editorials. These papers have mostly focused on pharmacokinetics and pharmacodynamics, biostatistics, and issues in pharmaceutical education. Dr. Sowinski teaches cardiovascular therapeutics, biostatistics, and research design to Pharm.D. and graduate students.

Timothy E. Welty, Pharm.D., FCCP, BCPS

Neurology

Dr. Welty is currently professor of pharmacy practice and chair of the Department of Clinical Sciences at Drake University in Des Moines, Iowa. He obtained his BS in Pharmacy from Butler University, completed a Pharm.D. and research fellowship in neuropharmacology and pharmacokinetics at the University of Minnesota, and holds a Master of Arts from Trinity International University.

Prior to holding his current position at Drake, Dr. Welty served as the chair and professor of pharmacy practice at the University of Kansas School of Pharmacy, adjunct professor in the Department of Neurology at the University of Kansas Medical Center, and on the faculties of Samford University, the University of Alabama Birmingham, the University of Cincinnati, North Dakota State University, and Purdue University.

An active practitioner, educator, and researcher in neuropharmacotherapy, Dr. Welty has focused his research and practice in epilepsy. He has published multiple research articles and several book chapters on epilepsy and antiepileptic drugs

Sheila M. Wilhelm, Pharm.D., BCPS

Gastrointestinal Disorders

Dr. Sheila Wilhelm is currently an Associate Professor within the Department of Pharmacy Practice at the Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University. She received her Doctor of Pharmacy degree from the University of Michigan followed by a pharmacy practice residency at MidMichigan Health. Her teaching, scholarly, and patient care activities focus mainly on gastroenterology, primarily inflammatory bowel diseases, as well as prevention and treatment of venous thromboembolism, and patient education.

Corey J. Witenko, PharmD, BCPS, BCCCP

Critical Care

Dr. Corey J. Witenko is a critical care clinical pharmacist in the surgery/trauma ICU at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York, New York. He received his PharmD degree from the University of Georgia, College of Pharmacy. Thereafter, he completed a PGY1 pharmacy residency at UF Health Jacksonville in Jacksonville, Florida, and a PGY2 critical care residency at the University of North Carolina Medical Center in Chapel Hill, North Carolina. Since then, he practiced as a critical care clinical pharmacist at the University of Alabama at Birmingham Hospital prior to coming to NewYork-Presbyterian Hospital in 2016. Currently, Dr. Witenko is the director for the PGY1 pharmacy residency program and has a faculty appointment as an instructor at the Weill Cornell Graduate School Master of Sciences in Health Sciences for Physician Assistants. His clinical and research interests focus on pharmacotherapy in the immediate post-trauma and post-surgical populations.

Kristin Zimmerman, Pharm.D., CGP, BCACP

Policy, Practice, and Regulatory Issues

Kristin Zimmerman is an associate professor within the VCU School of Pharmacy’s Department of Pharmacotherapy and Outcomes Science. Dr. Zimmerman received her B.S. (2006) and Pharm.D. (2008) degrees from the University of Connecticut and completed 2 years of postgraduate residency training to specialize in geriatrics (2008-2010). As a certified geriatric pharmacist and former MCPHS University faculty (2010-2015), she practiced within the VA Boston Healthcare System (2010-2015) as a clinical pharmacy specialist in geriatrics. In her role at VCU and as a member of the Center for Pharmacy Practice Innovation, Dr. Zimmerman practices within the Hayes E. Willis Health Center’s family medicine clinic developing novel pharmacy practice models for the care of adult outpatients. Her scholarship and clinical activities focus on medication reconciliation and appropriateness assessments, shared decision-making and patient-centered care, and regimen complexity and the deprescribing of unnecessary medications. Her interests in health policy center on quality initiatives that support primary, preventive, and older adult care services that coincide with patient-centered care; expanding the role of allied health professions; and access to comprehensive care services.